This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a Université de Montréal directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $745,875
Mechanisms of action of antiestrogens: towards improved treatment of relapse in ER+ breast cancer
CIHR · 2017 · Co-investigator
- $100,000
Antiestrogen-HDACi hybrid molecules for breast cancer treatment.
CIHR · 2012 · Principal investigator
Mechanisms of action of antiestrogens: towards improved treatment of relapse in ER+ breast cancer
Principal investigators: Mader, Sylvie N
Keywords: Antiestrogens; Bioluminescence Resonance Energy Transfer; Breast Cancer; Chromatin; Combination Therapies; Estrogen Receptor; Molecular And Cellular Biology; Pharmacology; Structure Function Analyses; Transcriptional Regulation
Antiestrogen-HDACi hybrid molecules for breast cancer treatment.
Principal investigators: Mader, Sylvie N; Gleason, James L
Keywords: Antiestrogens; Breast Cancer; Cell Culture; Drug Combinations; Estrogen Receptor; Histone Deacetylase Inhibitors; Hybrid Drugs; Pharmacokinetics; Structure Activity Relationship; Xenograft Models
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.